Welcome back. We hope you had a refreshing weekend and feel recharged. Now, of course, the routine returns with those meetings and deadlines. As you might expect, we are brewing the mandatory cup of stimulation. Please join us as we indulge and scan the news of the world. Hope your day goes well and do stay in touch...
Russia Approves Merck KGgA's MS Pill (Reuters)
Sanofi May Sell EU Research Sites To Covance (OutsourcingPharma)
J&J Sued Over Pediatric OTC Med Recalls (Reuters)
Another Canadian Province Cuts Generic Prices (PharmaTimes)
FDA To Review First Of Three New Diet Pills (Associated Press)
Sigma Pharma Wants Better Deal From Aspen (International Business Times)
Abbott Warns Against Further Healthcare Cuts (Irish Examiner)
Pfizer Works To Clean Contaminants From Michigan River (Holland Sentinel)
1 Comment
One of the real tragedies of Pharma downsizing is the closure of contract labs that do animal preclinical research. Last week a story ran in the Daily Record (see link below) about 30 beagles that were rescued by St. Hubert's Animal Shelter from an animal research facility that recently went out of business.
I fear that other animals may not fare so well.
http://www.dailyrecord.com/article/20100709/UPDATES01/307090006/30-rescued-beagles-up-for-adoption-at-St-Hubert-s-in-Madison